Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus

BMC Immunology

Volumn 10, Issue , 2009, Pages

  Gustafsson, Erika ^a,b   Haas, Pieter Jan ^c   Walse, Björn ^d   Hijnen, Marcel ^e   Furebring, Christina ^a   Ohlin, Mats ^b   van Strijp, Jos A G ^c   van Kessel, Kok P M ^c  

^a Alligator Bioscience AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d SARomics AB   (Sweden)

^e MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHEMOTAXIS INHIBITORY PROTEIN OF STAPHYLOCOCCUS AUREUS; COMPLEMENT COMPONENT C5A RECEPTOR; EPITOPE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; C5AR1 PROTEIN, HUMAN; CHEMOTAXIS INHIBITORY PROTEIN, STAPHYLOCOCCUS AUREUS; COMPLEMENT RECEPTOR; FORMYLPEPTIDE RECEPTOR; PEPTIDE; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLOW CYTOMETRY; IN VITRO STUDY; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN CONFORMATION; PROTEIN PURIFICATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE; SURFACE PLASMON RESONANCE; ANTIBODY COMBINING SITE; CHEMISTRY; CHEMOTAXIS; CONFORMATION; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; NEUTROPHIL; PATHOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SYNTHESIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BINDING SITES, ANTIBODY; CHEMOTAXIS; EPITOPE MAPPING; EPITOPES; IMMUNOGLOBULIN G; MOLECULAR CONFORMATION; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEUTROPHILS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; RECEPTORS, COMPLEMENT; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

EID: 63849165809     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-13     Document Type: Article

References (37)

1. De Haas CJ Veldkamp KE Peschel A Weerkamp F Van Wamel WJ Heezius EC Poppelier MJ Van Kessel KP Van Strijp JA Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent J Exp Med 2004, 199:687-695 2213298 14993252
2. Postma B Poppelier MJ van Galen JC Prossnitz ER van Strijp JA de Haas CJ van Kessel KP Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor J Immunol 2004, 172:6994-7001 15153520
3. Goldstein IM Weissmann G Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes J Immunol 1974, 113:1583-1588 4473046
4. Sacks T Moldow CF Craddock PR Bowers TK Jacob HS Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage J Clin Invest 1978, 61:1161-1167 372636 207729
5. Marder SR Chenoweth DE Goldstein IM Perez HD Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg J Immunol 1985, 134:3325-3331 3884709
6. Guo RF Ward PA Role of C5a in inflammatory responses Annu Rev Immunol 2005, 23:821-852 15771587
7. Hopkins P Belmont HM Buyon J Philips M Weissmann G Abramson SB Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis Arthritis Rheum 1988, 31:632-641 3259882
8. Huber-Lang M Sarma VJ Lu KT McGuire SR Padgaonkar VA Guo RF Younkin EM Kunkel RG Ding J Erickson R Curnutte JT Ward PA Role of C5a in multiorgan failure during sepsis J Immunol 2001, 166:1193-1199 11145701
9. Neumann E Barnum SR Tarner IH Echols J Fleck M Judex M Kullmann F Mountz JD Scholmerich J Gay S Muller-Ladner U Local production of complement proteins in rheumatoid arthritis synovium Arthritis Rheum 2002, 46:934-945 11953970
10. Grant EP Picarella D Burwell T Delaney T Croci A Avitahl N Humbles AA Gutierrez-Ramos JC Briskin M Gerard C Coyle AJ Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis J Exp Med 2002, 196:1461-1471 2194257 12461081
11. Woodruff TM Arumugam TV Shiels IA Reid RC Fairlie DP Taylor SM A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease J Immunol 2003, 171:5514-5520 14607958
12. Arumugam TV Shiels IA Woodruff TM Granger DN Taylor SM The role of the complement system in ischemia-reperfusion injury Shock 2004, 21:401-409 15087815
13. Rittirsch D Flierl MA Nadeau BA Day DE Huber-Lang M Mackay CR Zetoune FS Gerard NP Cianflone K Kohl J Gerard C Sarma JV Ward PA Functional roles for C5a receptors in sepsis Nat Med 2008, 14:551-557 18454156
14. Konteatis ZD Siciliano SJ Van Riper G Molineaux CJ Pandya S Fischer P Rosen H Mumford RA Springer MS Development of C5a receptor antagonists. Differential loss of functional responses J Immunol 1994, 153:4200-4205 7930622
15. Heller T Hennecke M Baumann U Gessner JE zu Vilsendorf AM Baensch M Boulay F Kola A Klos A Bautsch W Kohl J Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury J Immunol 1999, 163:985-994 10395696
16. Riley RD Sato H Zhao ZQ Thourani VH Jordan JE Fernandez AX Ma XL Hite DR Rigel DF Pellas TC Peppard J Bill KA Lappe RW Vinten-Johansen J Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization J Thorac Cardiovasc Surg 2000, 120:350-358 10917953
17. Strachan AJ Woodruff TM Haaima G Fairlie DP Taylor SM A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats J Immunol 2000, 164:6560-6565 10843715
18. Woodruff TM Strachan AJ Dryburgh N Shiels IA Reid RC Fairlie DP Taylor SM Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat Arthritis Rheum 2002, 46:2476-2485 12355496
19. Huber-Lang MS Riedeman NC Sarma JV Younkin EM McGuire SR Laudes IJ Lu KT Guo RF Neff TA Padgaonkar VA Lambris JD Spruce L Mastellos D Zetoune FS Ward PA Protection of innate immunity by C5aR antagonist in septic mice Faseb J 2002, 16:1567-1574 12374779
20. Wright AJ Higginbottom A Philippe D Upadhyay A Bagby S Read RC Monk PN Partridge LJ Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response Mol Immunol 2007, 44:2507-2517 2646901 17258808
21. Rowley MJ O'Connor K Wijeyewickrema L Phage display for epitope determination: A paradigm for identifying receptor-ligand interactions Biotechnol Annu Rev 2004, 10:151-188 15504706
22. Scott JK Smith GP Searching for peptide ligands with an epitope library Science 1990, 249:386-390 1696028
23. Luzzago A Felici F Tramontano A Pessi A Cortese R Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides Gene 1993, 128:51-57 7685301
24. Rowley MJ Scealy M Whisstock JC Jois JA Wijeyewickrema LC Mackay IR Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display J Immunol 2000, 164:3413-3419 10706737
25. Haas PJ de Haas CJ Poppelier MJ van Kessel KP van Strijp JA Dijkstra K Scheek RM Fan H Kruijtzer JA Liskamp RM Kemmink J The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules J Mol Biol 2005, 353:859-872 16213522
26. Gustafsson E Forsberg C Haraldsson K Lindman S Ljung L Furebring C Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus - an anti-inflammatory protein Protein Expr Purif 2009, 63:95-101 18950716
27. Haas PJ de Haas CJ Kleibeuker W Poppelier MJ van Kessel KP Kruijtzer JA Liskamp RM van Strijp JA N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor J Immunol 2004, 173:5704-5711 15494522
28. Cook AD Davies JM Myers MA Mackay IR Rowley MJ Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen J Autoimmun 1998, 11:205-211 9693968
29. Davies JM Cai YP Weir RC Rowley MJ Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries Virology 2000, 275:67-76 11017788
30. Osman AA Uhlig H Thamm B Schneider-Mergener J Mothes T Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies FEBS Lett 1998, 433:103-107 9738942
31. Ikuno N Scealy M Davies JM Whittingham SF Omagari K Mackay IR Rowley MJ A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display Hepatology 2001, 34:478-486 11526532
32. Peters EA Schatz PJ Johnson SS Dower WJ Membrane insertion defects caused by positive charges in the early mature region of protein pIII of filamentous phage fd can be corrected by prlA suppressors J Bacteriol 1994, 176:4296-4305 205641 8021215
33. Smith GP Petrenko VA Phage Display Chem Rev 1997, 97:391-410 11848876
34. Jin L Fendly BM Wells JA High resolution functional analysis of antibody-antigen interactions J Mol Biol 1992, 226:851-865 1380563
35. Geysen HM Mason TJ Rodda SJ Cognitive features of continuous antigenic determinants J Mol Recognit 1988, 1:32-41 2483922
36. McLafferty MA Kent RB Ladner RC Markland W M13 bacteriophage displaying disulfide-constrained microproteins Gene 1993, 128:29-36 8508957
37. DeLano WL The PyMOL Molecular Graphics System Palo Alto, CA: Delano Scientific LLC 2008 http://pymol.sourceforge.net/overview/index.htm